Sirt3在心肌梗死中的作用研究进展

黄传; 姜俐洋; 万春晓

doi:10.11659/jjssx.09E023129

您当前的位置：

首页 >

文章列表页 >

Sirt3在心肌梗死中的作用研究进展

综述 | 更新时间：2023-12-13

- Sirt3在心肌梗死中的作用研究进展
- Research progress on the role of Sirt3 in myocardial infarction
- 局解手术学杂志 2023年32卷第12期页码：1087-1090
- 作者机构：
  
  天津医科大学总医院康复医学科，天津 300052
- 作者简介：
  
  万春晓，E-mail：cwan@tmu.edu.cn
- 基金信息：
  
  天津市医学重点学科（专科）建设项目资助(TJYXZDXK-060B);天津市卫健委科技项目青年项目(TJWJ2023QN008)
- DOI：10.11659/jjssx.09E023129
  中图分类号： R714.252
- 纸质出版日期：2023-12-25，
  
  收稿日期：2023-09-29，
扫描看全文
黄传,姜俐洋,万春晓.Sirt3在心肌梗死中的作用研究进展[J].局解手术学杂志,2023,32(12):1087-1090.

HUANG Chuan,JIANG Li-yang,WAN Chun-xiao.Research progress on the role of Sirt3 in myocardial infarction[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(12):1087-1090.
黄传,姜俐洋,万春晓.Sirt3在心肌梗死中的作用研究进展[J].局解手术学杂志,2023,32(12):1087-1090. DOI： 10.11659/jjssx.09E023129.

HUANG Chuan,JIANG Li-yang,WAN Chun-xiao.Research progress on the role of Sirt3 in myocardial infarction[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(12):1087-1090. DOI： 10.11659/jjssx.09E023129.

摘要

心肌梗死是一种严重的心血管疾病，其会导致心肌能量代谢的紊乱。Sirt3作为一种重要的线粒体去乙酰化酶，在心肌梗死后的能量代谢调节中发挥重要作用。本综述旨在分析和总结Sirt3在心肌梗死后能量代谢调节中的研究进展，以期为心血管疾病的治疗提供新的理论和实践依据。

Abstract

Myocardial infarction is a serious cardiovascular disease that can disrupt the myocardial energy metabolism. Sirt3， as an important mitochondrial deacetylase， plays a crucial role in the regulation of energy metabolism after myocardial infarction. This review aims to analyze and summarize the research progress of Sirt3 in the regulation of energy metabolism after myocardial infarction， so as to provide new theoretical and practical basis for the treatment of cardiovascular diseases.

关键词

心肌梗死能量代谢Sirt3心血管疾病

Keywords

myocardial infarctionenergy metabolismSirt3cardiovascular disease

references

Roth GA，Mensah GA，Fuster V.The Global burden of cardiovascular diseases and risks：a compass for global action［J］.J Am Coll Cardiol，2020，76（25）：2980-2981.doi：10.1016/j.jacc.2020.11.021http://dx.doi.org/10.1016/j.jacc.2020.11.021.

Roth GA，Mensah GA，Johnson CO，et al.Global burden of cardiovascular diseases and risk factors，1990-2019：Update From the GBD 2019 Study［J］.J Am Coll Cardiol，2020，76（25）：2982-3021.doi：10.1016/j.jacc.2020.11.010http://dx.doi.org/10.1016/j.jacc.2020.11.010.

Golforoush P，Yellon DM，Davidson SM.Mouse models of atherosclerosis and their suitability for the study of myocardial infarction［J］.Basic Res Cardiol，2020，115（6）：73.doi：10.1007/s00395-020-00829-5http://dx.doi.org/10.1007/s00395-020-00829-5.

Mccarthy CP，Vaduganathan M，Mccarthy KJ，et al.Left Ventricular thrombus after acute myocardial infarction：screening，prevention，and treatment［J］.JAMA Cardiol，2018，3（7）：642-649.doi：10.1001/jamacardio.2018.1086http://dx.doi.org/10.1001/jamacardio.2018.1086.

Doenst T，Haverich A，Serruys P，et al.PCI and CABG for treating stable coronary artery disease：JACC review topic of the week［J］.J Am Coll Cardiol，2019，73（8）：964-976.doi：10.1016/j.jacc.2018. 11.053http://dx.doi.org/10.1016/j.jacc.2018.11.053.

Stanley WC，Recchia FA，Lopaschuk GD.Myocardial substrate metabolism in the normal and failing heart［J］.Physiol Rev，2005，85（3）：1093-1129.doi：10.1152/physrev.00006.2004http://dx.doi.org/10.1152/physrev.00006.2004.

Fraccarollo D，Galuppo P，Bauersachs J.Novel therapeutic approaches to post-infarction remodelling［J］.Cardiovasc Res，2012，94（2）：293-303.doi：10.1093/cvr/cvs109http://dx.doi.org/10.1093/cvr/cvs109.

Viola M，De Jager SCA，Sluijter JPG.Targeting Inflammation after myocardial infarction：a therapeutic opportunity for extracellular vesicles？［J］.Int J Mol Sci，2021，22（15）：7831.doi：10.3390/ijms22157831http://dx.doi.org/10.3390/ijms22157831.

Zhang Q，Wang L，Wang S，et al.Signaling pathways and targeted therapy for myocardial infarction［J］.Signal Transduct Target Ther，2022，7（1）：78.doi：10.1038/s41392-022-00925-zhttp://dx.doi.org/10.1038/s41392-022-00925-z.

Pan Z，Dong H，Huang N，et al.Oxidative stress and inflammation regulation of sirtuins：New insights into common oral diseases［J］.Front Physiol，2022，13：953078.doi：10.3389/fphys.2022.953078http://dx.doi.org/10.3389/fphys.2022.953078.

Xu Y，Wan W.Acetylation in the regulation of autophagy［J］.Autophagy，2023，19（2）：379-387.doi：10.1080/15548627.2022. 2062112http://dx.doi.org/10.1080/15548627.2022.2062112.

Zhou S，Tang X，Chen HZ.Sirtuins and insulin resistance［J］.Front Endocrinol （Lausanne），2018，9：748.doi：10.3389/fendo.2018. 00748http://dx.doi.org/10.3389/fendo.2018.00748.

He L，Liu F，Li J.Mitochondrial sirtuins and doxorubicin-induced cardiotoxicity［J］.Cardiovasc Toxicol，2021，21（3）：179-191.doi：10.1007/s12012-020-09626-xhttp://dx.doi.org/10.1007/s12012-020-09626-x.

Khayatan D，Razavi SM，Arab ZN，et al.Regulatory effects of statins on SIRT1 and other sirtuins in cardiovascular diseases［J］.Life （Basel），2022，12（5）：760.doi：10.3390/life12050760http://dx.doi.org/10.3390/life12050760.

Dikalov S，Dikalova A.Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension［J］.Curr Opin Nephrol Hypertens，2022，31（2）：151-156.doi：10.1097/mnh.0000000000000771http://dx.doi.org/10.1097/mnh.0000000000000771.

Lombard DB，Alt FW，Cheng HL，et al.Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation［J］.Mol Cell Biol，2007，27（24）：8807-8814.doi：10.1128/mcb.01636-07http://dx.doi.org/10.1128/mcb.01636-07.

Cooper HM，Spelbrink JN.The human SIRT3 protein deacetylase is exclusively mitochondrial［J］.Biochem J，2008，411（2）：279-285.doi：10.1042/bj20071624http://dx.doi.org/10.1042/bj20071624.

Dittenhafer-Reed KE，Richards AL，Fan J，et al.SIRT3 mediates multi-tissue coupling for metabolic fuel switching［J］.Cell Metab，2015，21（4）：637-646.doi：10.1016/j.cmet.2015.03.007http://dx.doi.org/10.1016/j.cmet.2015.03.007.

Koentges C，Cimolai MC，Pfeil K，et al.Impaired SIRT3 activity mediates cardiac dysfunction in endotoxemia by calpain-dependent disruption of ATP synthesis［J］.J Mol Cell Cardiol，2019，133：138-147.doi：10.1016/j.yjmcc.2019.06.008http://dx.doi.org/10.1016/j.yjmcc.2019.06.008.

Cho CS，Lombard DB，Lee JH.SIRT3 as a regulator of hepatic autophagy［J］.Hepatology，2017，66（3）：700-702.doi：10.1002/hep.29271http://dx.doi.org/10.1002/hep.29271.

He W，Newman JC，Wang MZ，et al.Mitochondrial sirtuins：regulators of protein acylation and metabolism［J］.Trends Endocrinol Metab，2012，23（9）：467-476.doi：10.1016/j.tem.2012.07.004http://dx.doi.org/10.1016/j.tem.2012.07.004.

Klishadi MS，Zarei F，Hejazian SH，et al.Losartan protects the heart against ischemia reperfusion injury：sirtuin3 involvement［J］.J Pharm Pharm Sci，2015，18（1）：112-123.doi：10.18433/j3xg7thttp://dx.doi.org/10.18433/j3xg7t.

Porter GA，Urciuoli WR，Brookes PS，et al.SIRT3 deficiency exacerbates ischemia-reperfusion injury：implication for aged hearts［J］.Am J Physiol Heart Circ Physiol，2014，306（12）：H1602-H1609.doi：10.1152/ajpheart.00027.2014http://dx.doi.org/10.1152/ajpheart.00027.2014.

Parodi-Rullan R，Barreto-Torres G，Ruiz L，et al.Direct renin inhibition exerts an anti-hypertrophic effect associated with improved mitochondrial function in post-infarction heart failure in diabetic rats［J］.Cell Physiol Biochem，2012，29（5-6）：841-850.doi：10.1159/000178526http://dx.doi.org/10.1159/000178526.

Mihanfar A，Nejabati HR，Fattahi A，et al.SIRT3-mediated cardiac remodeling/repair following myocardial infarction［J］.Biomed Pharmacother，2018，108：367-373.doi：10.1016/j.biopha.2018. 09.079http://dx.doi.org/10.1016/j.biopha.2018.09.079.

Koentges C，Pfeil K，Schnick T，et al.SIRT3 deficiency impairs mitochondrial and contractile function in the heart［J］.Basic Res Cardiol，2015，110（4）：36.doi：10.1007/s00395-015-0493-6http://dx.doi.org/10.1007/s00395-015-0493-6.

Bochaton T，Crola-Da-Silva C，Pillot B，et al.Inhibition of myocardial reperfusion injury by ischemic postconditioning requires sirtuin 3-mediated deacetylation of cyclophilin D［J］.J Mol Cell Cardiol，2015，84：61-69.doi：10.1016/j.yjmcc.2015.03.017http://dx.doi.org/10.1016/j.yjmcc.2015.03.017.

He X，Zeng H，Chen JX.Ablation of SIRT3 causes coronary microvascular dysfunction and impairs cardiac recovery post myocardial ischemia［J］.Int J Cardiol，2016，215：349-357.doi：10.1016/j.ijcard. 2016.04.092http://dx.doi.org/10.1016/j.ijcard.2016.04.092.

Bharathi SS，Zhang Y，Mohsen AW，et al.Sirtuin 3 （SIRT3） protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site［J］.J Biol Chem，2013，288（47）：33837-33847.doi：10.1074/jbc.M113.510354http://dx.doi.org/10.1074/jbc.M113.510354.

Rardin MJ，Newman JC，Held JM，et al.Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways［J］.Proc Natl Acad Sci U S A，2013，110（16）：6601-6606.doi：10.1073/pnas.1302961110http://dx.doi.org/10.1073/pnas.1302961110.

Chen T，Liu J，Li N，et al.Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD［J］.PLoS One，2015，10（3）：e0118909.doi：10.1371/journal.pone.0118909http://dx.doi.org/10.1371/journal.pone.0118909.

Chen X，Wang Q，Shao M，et al.Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPARα pathway［J］.Biomed Pharmacother，2019，120：109487.doi：10.1016/j.biopha.2019.109487http://dx.doi.org/10.1016/j.biopha.2019.109487.

Cheng P，Zeng W，Li L，et al.PLGA-PNIPAM Microspheres loaded with the gastrointestinal nutrient NaB ameliorate cardiac dysfunction by activating Sirt3 in acute myocardial infarction［J］.Adv Sci （Weinh），2016，3（12）：1600254.doi：10.1002/advs.201600254http://dx.doi.org/10.1002/advs.201600254.

Fan J，Shan C，Kang HB，et al.Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex［J］.Mol Cell，2014，53（4）：534-548.doi：10.1016/j.molcel.2013.12.026http://dx.doi.org/10.1016/j.molcel.2013.12.026.

Jing E，O'neill BT，Rardin MJ，et al.Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation［J］.Diabetes，2013，62（10）：3404-3417.doi：10.2337/db12-1650http://dx.doi.org/10.2337/db12-1650.

Zhang X，Ji R，Liao X，et al.MicroRNA-195 regulates metabolism in failing myocardium via alterations in Sirtuin 3 expression and mitochondrial protein acetylation［J］.Circulation，2018，137（19）：2052-2067.doi：10.1161/circulationaha.117.030486http://dx.doi.org/10.1161/circulationaha.117.030486.

Nadtochiy SM，Wang YT，Zhang J，et al.Potential mechanisms linking SIRT activity and hypoxic 2-hydroxyglutarate generation：no role for direct enzyme （de）acetylation［J］.Biochem J，2017，474（16）：2829-2839.doi：10.1042/bcj20170389http://dx.doi.org/10.1042/bcj20170389.

Grillon JM，Johnson KR，Kotlo K，et al.Non-histone lysine acetylated proteins in heart failure［J］.Biochim Biophys Acta，2012，1822（4）：607-614.doi：10.1016/j.bbadis.2011.11.016http://dx.doi.org/10.1016/j.bbadis.2011.11.016.

Hallows WC，Lee S，Denu JM.Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases［J］.Proc Natl Acad Sci U S A，2006，103（27）：10230-10235.doi：10.1073/pnas.0604392103http://dx.doi.org/10.1073/pnas.0604392103.

Ma LL，Kong FJ，Ma YJ，et al.Hypertrophic preconditioning atte-nuates post-myocardial infarction injury through deacetylation of isocitrate dehydrogenase 2［J］.Acta Pharmacol Sin，2021，42（12）：2004-2015.doi：10.1038/s41401-021-00699-0http://dx.doi.org/10.1038/s41401-021-00699-0.

Ma L，Shi H，Li Y，et al.Hypertrophic preconditioning attenuates myocardial ischemia/reperfusion injury through the deacetylation of isocitrate dehydrogenase 2［J］.Sci Bull （Beijing），2021，66（20）：2099-2114.doi：10.1016/j.scib.2021.04.008http://dx.doi.org/10.1016/j.scib.2021.04.008.

Zhong L，Mostoslavsky R.Fine tuning our cellular factories：sirtuins in mitochondrial biology［J］.Cell Metab，2011，13（6）：621-626.doi：10.1016/j.cmet.2011.05.004http://dx.doi.org/10.1016/j.cmet.2011.05.004.

Ahn BH，Kim HS，Song S，et al.A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis［J］.Proc Natl Acad Sci U S A，2008，105（38）：14447-14452.doi：10.1073/pnas.080 3790105http://dx.doi.org/10.1073/pnas.0803790105.

Finley LW，Haas W，Desquiret-Dumas V，et al.Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity［J］.PLoS One，2011，6（8）：e23295.doi：10.1371/journal.pone.0023295http://dx.doi.org/10.1371/journal.pone.0023295.

Wu YT，Lee HC，Liao CC，et al.Regulation of mitochondrial F（o）F（1）ATPase activity by Sirt3-catalyzed deacetylation and its deficiency in human cells harboring 4977bp deletion of mitochondrial DNA［J］.Biochim Biophys Acta，2013，1832（1）：216-227.doi：10.1016/j.bbadis.2012.10.002http://dx.doi.org/10.1016/j.bbadis.2012.10.002.

Zhang M，Zhao Z，Shen M，et al.Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3［J］.Biochim Biophys Acta Mol Basis Dis，2017，1863（8）：1962-1972.doi：10.1016/j.bbadis.2016.09.003http://dx.doi.org/10.1016/j.bbadis.2016.09.003.

Yu L，Gong B，Duan W，et al.Melatonin ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function：role of AMPK-PGC-1α-SIRT3 signaling［J］.Sci Rep，2017，7：41337.doi：10.1038/srep41337http://dx.doi.org/10.1038/srep41337.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

利用Seahorse XF-96探讨不同细胞浓度和血清对线粒体功能的影响